“It benefits no one — least of all the labels — to plunge ahead with burdensome litigation on a theory the Supreme Court may soon reject,” the company argues.
“It benefits no one — least of all the labels — to plunge ahead with burdensome litigation on a theory the Supreme Court may soon reject,” the company argues.